Antithrombotic Treatments in Patients with Chronic Coronary Artery Disease or Peripheral Artery Disease: A Systematic Review of Randomised Controlled Trials
Aims. Acetylsalicylic acid (ASA) is widely used for the prevention of atherothrombotic events in patients with chronic coronary artery disease (CAD) and peripheral artery disease (PAD), but the risk of vascular events remains high. We aimed at identifying randomised controlled trials (RCTs) on antit...
Saved in:
Main Authors: | Rupert Bauersachs (Author), Olivia Wu (Author), Jean-Baptiste Briere (Author), Kevin Bowrin (Author), Katarzyna Borkowska (Author), Anna Jakubowska (Author), Vanessa Taieb (Author), Mondher Toumi (Author), Maria Huelsebeck (Author) |
---|---|
Format: | Book |
Published: |
Hindawi-Wiley,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Burden of Coronary Artery Disease and Peripheral Artery Disease: A Literature Review
by: Rupert Bauersachs, et al.
Published: (2019) -
Efficacy and Safety of Rivaroxaban Compared with Other Therapies Used in Patients with Peripheral Artery Disease Undergoing Peripheral Revascularization: A Systematic Literature Review and Network Meta-Analysis
by: Rupert Bauersachs, et al.
Published: (2021) -
Meta-analysis of real-world evidence comparing non-vitamin K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibrillation
by: Craig I. Coleman, et al.
Published: (2019) -
Real-world cost-effectiveness of rivaroxaban and apixaban vs VKA in stroke prevention in non-valvular atrial fibrillation in the UK
by: Kevin Bowrin, et al.
Published: (2020) -
Characteristics of the Russian population of patients with coronary artery disease or peripheral artery disease in the XATOA registry
by: V. S. Arakelyan, et al.
Published: (2024)